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Background: Reactive oxygen species (ROS) have been implicated in the pathophysiology of the brain after ischemic
stroke. In this study, we investigate the generation of brain ROS after transient focal ischemia in mice using a radical
trapping radiotracer, [3H]-labeled N-methyl-2,3-diamino-6-phenyl-dihydrophenanthridine ([3H]hydromethidine), which
we recently reported as a ROS imaging probe. We also examined the effect of dimethylthiourea (DMTU), a hydroxyl
radical scavenger, on brain ROS generation and infarct volume after transient focal ischemia in mice.
Methods: [3H]Hydromethidine was intravenously injected into mice at 1, 2, 5, and 7 h after transient middle cerebral
artery occlusion (tMCAO), and then, the brain autoradiogram was acquired at 60 min after tracer injection. Brain infarct
volumes at 24 h after tMCAO were assessed by 2,3,5-triphenyltetrazolium chloride staining.
Results: Accumulation of radioactivity was observed in the ipsilateral striatum and cortex at 1 h after tMCAO. The
increase of radioactivity was attenuated at 2 h after tMCAO and then became maximized at 5 h. The high accumulation
of radioactivity remained until 7 h after tMCAO. DMTU treatment significantly attenuated the accumulation of
radioactivity in the ipsilateral hemisphere at 1, 5, and 7 h after tMCAO. Brain infarct volumes were also significantly
reduced in DMTU-treated mice at 24 h after tMCAO.
Conclusions: These results indicated that [3H]hydromethidine is a useful radiotracer for detecting in vivo brain ROS
generation such as hydroxyl radical after ischemic injury.
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Reactive oxygen species (ROS) have been implicated in
the pathogenesis of various neurological disorders, such
as ischemia, trauma, and degenerative disease [1–3].
Ischemic stroke can induce pathophysiological events
such as amino acid excitotoxicity, ionic imbalance, and
oxidative stress [4, 5]. Cumulative evidence suggests that
ROS are important mediators of cell injury in the ischemic
brain [6, 7]. Oxidative stress can primarily lead to the
formation of superoxide radical (O2 · −) and nitric oxide
(·NO), and then, highly reactive ROS including hydroxyl* Correspondence: kohji.abe@shionogi.co.jp
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provided the original work is properly creditedradical (OH · −) and peroxynitrite (ONOO−) are generated
by ischemia and reperfusion [8, 9]. ROS which induce lipid
peroxidation, proteins, and DNA damage in ischemic brain
tissue trigger molecular pathways leading to necrosis,
apoptosis, and neuroinflammation with subsequent
neuronal death and memory and/or motor dysfunction.
Therefore, it is important to know the ROS generation in
the brain following ischemia/reperfusion in the patho-
physiologic process leading to ischemic tissue damage.
To obtain direct evidence of ROS generation in disease
pathogenesis, highly sensitive and specific optical probes
(fluorescent, luminescent, or chemiluminescent probes)
for detecting ROS are being developed [10–13]. However,
it is very difficult to directly detect ROS in the brain
because they are extremely reactive and their life span is
very short. In the brain during or after ischemia, ROSe distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
Fig. 1 Schematic diagram of the experimental protocol. a ROS imaging
assessment using autoradiography (ARG) with [3H]hydromethidine
(3H-HM) at 1, 2, 5, and 7 h after tMCAO (90 min) in the saline
group (n = 7–8 in each time point). b ROS imaging assessment using
ARG using 3H-HM at 1, 5, and 7 h after tMCAO (90 min) in the DMTU
group (n = 5–8 in each time point). c BBB permeability assessment
using contrast enhanced MRI with Gd-DTPA at 1, 5, and 7 h after
tMCAO (90 min) in the saline or DMTU group (n = 3–5 at each time
point). d Cerebral infarction assessment using T2-MRI and TTC staining
at 24 h after tMCAO (90 min) in the saline and DMTU groups
(n= 12–13 in each group). Saline or DMTU was injected 30 min before
initiation of MCAO. All MRI experiments were performed under
isoflurane anesthesia. ADC apparent diffusion coefficient, T2 T2-weighted
MR imaging, Gd-DTPA gadolinium diethylenetriaminepentaacetate, TTC
2,3,5-triphenyltetrazolium chloride
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ance and a microdialysis method [14, 15]. Murakami et al.
[16] have reported that hydroethidine can detect the
O2 · − produced by occlusion of the middle cerebral
artery using mutant mice with a heterozygous knock-out
gene encoding mitochondrial manganese superoxide dis-
mutase (Mn-SOD). The areas of ROS in both the ischemic
core and the peri-infarct area in the permanent and transi-
ent middle cerebral artery occlusion (tMCAO) model
were detected by using a novel fluorescence probe [17].
Striatal ROS generation in ischemic brain was measured
by using salicylate, a hydroxyl radical trapping agent, and
a microdialysis method [18].
We have recently reported the usefulness of the radical
trapping radiotracer, [3H]-labeled N-methyl-2,3-diamino-6-
phenyl-dihydrophenanthridine ([3H]hydromethidine) for
detecting ROS generation in the brain [19]. We have
already shown that [3H]hydromethidine is converted to
oxidized products by a superoxide radical (O2 · −) and a
hydroxyl radical (OH · −). Brain ROS generation induced
by cerebral microinjection of sodium nitroprusside could
be autoradiographically detected by intravenous admin-
istration of [3H]hydromethidine. We concluded that
[3H]hydromethidine rapidly and freely penetrated into
the brain where it was rapidly converted to oxidized
forms, which were trapped there in response to ROS.
In the present study, we investigated the spatiotemporal
changes of ROS generation after ischemia/reperfusion in
the tMCAO model mouse using the radical trapping
radiotracer [3H]hydromethidine. In addition, the effects of
1,3-dimethyl-2-thiourea (DMTU), a hydroxyl radical
scavenger, on ROS generation and ischemic damage
following tMCAO in mice were also assessed to determine
whether its effect might be responsible for hydroxyl
radical scavenging action.
Methods
Animals and dimethylthiourea (DMTU) administration
All animal experiments in the present study were reviewed
and approved by the Institutional Animal Care and Use
Committee of Shionogi Research Laboratories (Osaka,
Japan) and were consistent with the internal guidelines for
animal experiments and in adherence to the ethics policy
of Shionogi & Co., Ltd (Osaka, Japan). Male C57BL/6 J
mice were obtained from CLEA Japan, Inc. (Tokyo, Japan).
They were allowed free access to chow and tap water
and housed in a temperature-controlled room main-
tained on a 12-h light/dark cycle with lights on at
8:00 a.m. At 9–11 weeks of age, the mice were ran-
domly assigned to each experiment (Fig. 1a, b, ROS
imaging using autoradiography with [3H]hydromethidine;
Fig. 1c, BBB permeability using contrast-enhanced
magnetic resonance imaging (MRI) with gadolinium
diethylenetriaminepentaacetate (Gd-DTPA); Fig. 1d, cerebralinfarction using T2-MRI and 2,3,5-triphenyltetrazolium
chloride (TTC) staining).
DMTU (Sigma-Aldrich, St. Louis, MO, USA), a hydroxyl
radical scavenger, was dissolved in saline. Mice were given
200 mg/kg DMTU (20 mg/mL) or saline intraperitoneally
30 min before tMCAO. This dose was selected based on a
previous study indicating its neuro protective effect in the
in vivo ischemic model [20].
Transient middle cerebral artery occlusion (tMCAO)
Mice were anesthetized with isoflurane: 5 % induction
and 1.5–2 % maintenance. Body temperature was main-
tained at 37 ± 0.5 °C using a hot plate during surgery.
tMCAO was induced using the intraluminal filament
technique. Briefly, in the supine position, a nylon 8–0
monofilament suture (Ethicon, Somerville, NJ, USA)
coated with silicone resin (Xantopren; Bayer Dental
Material, Osaka, Japan) was inserted from the left
common carotid artery into the internal carotid artery to
occlude the origin of the middle cerebral artery. Reperfu-
sion was performed by withdrawing the suture 90 min
after MCAO. Successful occlusion of the middle cerebral
artery was verified using MRI (Agilent 7 T/210, Agilent
Technologies, CA, USA) because diffusion-weighted
Fig. 2 Typical autoradiograms of the brain obtained at 60 min after
[3H]hydromethidine injection to mice. Typical autoradiograms of the
brain after intravenous injection of [3H]hydromethidine to mice treated
with saline or DMTU (200 mg/kg, i.p.) 30 min before tMCAO (90 min).
Coronal sections at the level of the striatum and hippocampus were
prepared at 1, 2, 5, and 7 h after ischemia/reperfusion of MCA in mice.
Regions of interest (ROIs) were marked on the MRI-T2 images in order
to quantify the radioactivity concentration
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maps have been established as markers of acute ischemic
brain injury. For MRI scans, the animals were subjected
to anesthesia using isoflurane (5 % induction, 1.5–2 %
maintenance). Mice were placed in a folder for MRI
measurement 60 min after MCAO. Respiration rate
was monitored by a pneumatic sensor (SA Instruments,
Stony Brook, NY, USA). Body temperature was monitored
with a rectal fiber-optic probe, and constant warm airflow
was utilized to avoid hypothermia. DWI was acquired by
EPI sequence. The imaging parameters were TR = 3000 ms,
TE = 38.94 ms, shot = 8, matrix size = 0.2 × 0.2 mm2,
number of averages = 2, number of slices = 6, slice
thickness = 0.75 mm, b = 0 and 1000 s/mm2, and three
diffusion directions. ADC map was calculated from
DWI using VnmrJ version 4.0 (Agilent Technologies,
CA, USA). From DWI images, pixel-by-pixel maps of
ADC were estimated. The reduction area in ADC was
calculated from six slices based on the threshold
value (0.52 × 10–3 mm2/s).
In vivo ROS detection by [3H]hydromethidine
[3H]Hydromethidine (specific activity: 74 GBq/mmol,
radiochemical purity: 98.8 %) was synthesized by N-
methylation using [methyl-3H]methyl nosylate as de-
scribed previously [19]. [3H]Hydromethidine was diluted
with distilled water containing 5 % dimethyl sulfoxide
(DMSO) (v/v), giving 95.7 % radiochemical purity.
[3H]Hydromethidine (740 kBq) was dissolved in an
aqueous solution (5 % DMSO, v/v) and was injected
intravenously into the tail vein of mice at 1, 2, 5, and 7 h
after tMCAO. The mice were sacrificed by decapitation
at 60 min after tracer injection under deep anesthesia
with isoflurane. The brains were rapidly removed and
frozen, and sections (20 μm thick) were prepared using a
cryostat. The sections were exposed to an imaging
plate (BAS-TR, GE Healthcare, Tokyo, Japan) for
14 days. After exposure, the plates were read with
an FLA-3000 instrument (Fujifilm Corp.). To quan-
tify the radioactivity in the autoradiograph, regions
of interest (ROIs) were set as shown Fig. 2, and the
photo-stimulated luminescence (PSL) value for each
ROI ((PSL − Background)/mm2) was determined using
Multi Gauge version 2.3 (Fujifilm Corp.) and was
calibrated at becquerel per milligram of tissue using the
[3H]-scale (RPA507, American Radiolabeled Chemicals,
Inc., St. Louis, MO, USA).
Measurement of BBB permeability
To evaluate the BBB permeability, 0.5 mmol/kg of
Gd-DTPA (Magnevist, Bayer Schering Pharma, Berlin,
Germany) was injected into mice 10 min before MR
imaging. T1-weighted images (T1WI) were acquired
by spin echo multi-slice sequence before and afterinjection of Gd-DTPA. The imaging parameters were
TR = 500 ms, TE = 10.35 ms, FOV = 25.6 × 25.6 mm,
matrix = 96 × 96, slice thickness = 1.0 mm, average = 4,
and dummy = 2. After T1WI, T2-weighted images were
acquired by spin echo sequence. The imaging parameters
were TR = 2500 ms, TE = 50 ms, and average = 1. Image
analysis was performed using ImageJ (NIH, Bethesda,
MD). Briefly, the percent increase in MRI signal intensity
images compared to the respective pixel in the pre-
injection images was calculated. To quantify the BBB
leakage areas, we set ROIs in two slices shown in
Fig. 4a. The threshold was set at the mean percent
increase plus two standard deviations in the normal
hemisphere. A higher percent increase value than the
threshold was considered as BBB disruption areas.
Measurement of infarct volume
At 24 h after reperfusion of MCAO, the mice were anes-
thetized by inhalation of 4.0 % isoflurane and killed by de-
capitation. The brains were quickly removed and chilled in
ice-cold saline for 30 s, and 2-mm-thick coronal slices were
Table 1 Radioactivity concentration of the brain after intravenous injection of [3H]hydromethidine to tMCAO mice treated with
saline and DMTU
Brain region CTX-1 (Bq/mg) CTX-2 (Bq/mg) CTX-3 (Bq/mg) STR-1 (Bq/mg) STR-2 (Bq/mg) HIP (Bq/mg) TH (Bq/mg)
Control Right 30.5 ± 2.7 30.7 ± 3.0 29.1 ± 1.3 30.5 ± 2.3 31.2 ± 2.5 30.6 ± 2.7 35.3 ± 3.6
Left 30.2 ± 2.7 31.0 ± 2.8 29.6 ± 2.5 30.3 ± 2.5 31.2 ± 2.7 30.2 ± 3.7 34.9 ± 3.9
tMCAO + Saline 1 h Right (C) 25.9 ± 2.0 26.1 ± 1.2 26.3 ± 2.0 26.5 ± 1.4 27.0 ± 1.5 29.9 ± 2.1 29.8 ± 2.5
Left (I) 28.0 ± 1.6 29.1 ± 1.1 33.4 ± 5.0 41.9 ± 7.2 64.4 ± 17.2 34.8 ± 6.0 32.7 ± 4.6
2 h Right (C) 37.9 ± 9.1 37.6 ± 8.9 37.0 ± 8.3 39.1 ± 9.0 39.3 ± 9.5 43.6 ± 12.0 42.2 ± 8.8
Left (I) 36.4 ± 6.5 36.9 ± 6.8 37.0 ± 7.3 44.9 ± 23.8 50.4 ± 31.4 49.1 ± 9.5 40.7 ± 5.5
5 h Right (C) 21.4 ± 2.6 21.3 ± 2.2 20.9 ± 2.4 22.1 ± 2.9 22.7 ± 2.9 23.8 ± 2.8 24.4 ± 2.8*
Left (I) 31.1 ± 7.2 30.0 ± 6.5 28.7 ± 10.0 62.5 ± 18.5* 68.4 ± 19.8* 49.7 ± 20.2 34.2 ± 12.4
7 h Right (C) 36.2 ± 5.5 36.0 ± 5.5 35.6 ± 5.4 37.7 ± 5.8 38.1 ± 5.7 40.3 ± 7.5 41.6 ± 4.6
Left (I) 42.6 ± 11.0 44.7 ± 14.1* 48.3 ± 13.5** 64.7 ± 15.5** 72.7 ± 18.2** 62.2 ± 21.2** 49.5 ± 10.6*
tMCAO + DMTU 1 h Right (C) 34.6 ± 7.7 34.7 ± 7.1 33.5 ± 5.8 35.2 ± 6.6 36.1 ± 7.2 41.4 ± 8.3 38.3 ± 7.6
Left (I) 33.1 ± 6.8 33.5 ± 5.8 35.2 ± 7.4 34.0 ± 9.8 42.8 ± 20.6 43.7 ± 15.1 38.2 ± 6.9
5 h Right (C) 38.6 ± 4.9 38.6 ± 4.7 38.1 ± 4.5 40.8 ± 5.9 49.2 ± 7.3** 44.3 ± 5.8
Left (I) 46.4 ± 13.5* 46.5 ± 10.0* 46.0 ± 11.6* 62.5 ± 19.9* 69.1 ± 18.8* 51.1 ± 12.0 41.3 ± 4.2
7 h Right (C) 62.4 ± 10.5** 61.6 ± 10.0** 61.2 ± 9.5** 64.8 ± 11.4** 64.4 ± 11.6** 78.3 ± 14.0** 66.9 ± 10.9**
Left (I) 63.8 ± 10.7** 64.3 ± 10.1** 64.2 ± 8.3** 79.0 ± 19.5** 80.6 ± 19.6** 76.7 ± 15.1** 65.8 ± 11.2**
[3H]Hydromethidine was intravenously injected into mice treated with saline or DMTU (200 mg/kg, i.p.) 30 min before tMCAO (90 min). Coronal sections at the
level of the striatum and hippocampus were prepared at 1, 2, 5, and 7 h after ischemia/reperfusion of MCA in mice. Data are expressed as mean ± SD (Bq/mg,
n = 5–8 for each time point)
C contralateral, I ipsilateral
*P < 0.05, **P < 0.01, as compared with control mice
Abe et al. EJNMMI Research  (2015) 5:37 Page 4 of 9cut with a tissue slicer. The slices were stained with 2.0 %
TTC (Sigma) solution at 37 °C for 10 min and then
fixed with 4.0 % phosphate buffered formalin solution.
Two sections obtained were scanned with an image
scanner and quantified using NIH ImageJ software.
Unstained areas (pale colored) were defined as ischemic
lesions. The infarct area in each slice was measured
using the following formula: ((area of the contralateral
hemisphere − area of non-ischemic ipsilateral hemisphere)/
area of the whole contralateral hemisphere) × 100. The
striatum, cortex, hippocampus, thalamus, and total infarct
volumes were determined and presented as a percentage of
the volume of the contralateral hemisphere [21].Statistical analysis
Data are presented as means ± SD Data were analyzed
using analysis of variance (ANOVA) followed by
Dunnett’s test for multiple comparisons. Student’s t test
for two samples was also used. Differences with a value of
P < 0.05 were considered statistically significant.Results
Brain ROS following tMCAO in mice pretreated with
saline or DMTU
Figure 2 shows typical autoradiograms of the brain
obtained at 60 min after [3H]hydromethidine injection
to mice treated with saline or DMTU (200 mg/kg,intraperitoneally (i.p.)) 30 min before tMCAO. Table 1
and Fig. 3 show the time change of brain ROS generation
detected by [3H]hydromethidine in tMCAO mouse pre-
treated with saline or DMTU.
In tMCAO mouse, increased radioactivity was observed
in the ipsilateral hemisphere. Radioactivity was seen in the
striatum, cortex, and adjacent brain areas. We also found
that in some mice, radioactivity accumulation was
observed in the hippocampus. The increase in radio-
activity indicating ROS generation was first observed
in the ipsilateral striatum and cortex 1 h after tMCAO in
mice. The increase of radioactivity was attenuated at 2 h
after tMCAO, and then, it reached maximum at 5 h.
The high accumulation of radioactivity remained until
7 h after tMCAO. In the striatum (STR-2), the radioactivity
concentrations of the ipsilateral side to the contralateral
side were 239 % at 1 h, 299 % at 5 h, and 192 % at 7 h after
tMCAO. DMTU treatment significantly attenuated the ac-
cumulation of radioactivity in the ipsilateral hemisphere at
1, 5, and 7 h after tMCAO. In addition, DMTU treatment
significantly increased the concentration of radioactivity in
the contralateral hemisphere at 7 h after tMCAO (Table 1).BBB permeability following tMCAO in mice pretreated
with saline or DMTU
Figure 4a shows typical contrast-enhanced MR images in
tMCAO mice treated with saline or DMTU. As shown
Fig. 3 Time changes in brain ROS generation detected by [3H]hydromethidine in tMCAO mouse treated with saline and DMTU. [3H]Hydromethidine
was intravenously injected into mice treated with saline or DMTU (200 mg/kg, i.p.) 30 min before tMCAO (90 min). Coronal sections at the level of the
striatum and hippocampus were prepared at 1, 2, 5, and 7 h after ischemia/reperfusion of MCA in mice. Radioactivity concentrations in the brain
including the cortex, striatum, hippocampus, and thalamus were calculated from the autoradiograms based on the ROIs drawn on MRI images (Fig. 2)
and are presented as the percentage of the contralateral side. Data are expressed as mean ± SD (n = 5–8 for each time point). *P < 0.05, **P < 0.01, as
compared with control mice
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enhancement in the cortex and striatum (Fig. 4b) showed
Gd-DTPA leakage meaning BBB disruption was observed
in the ipsilateral cortex and striatum at 7 h after ischemia/
reperfusion. At 1 and 5 h, BBB leakage was not clearly
observed in the ipsilateral cortex and striatum. In the
group of DMTU treatment, the area of leakage was
increased in the striatum at 7 h after ischemia/reperfusion.DMTU treatment slightly decreased the area of leakage in
the cortex at 7 h after ischemia/reperfusion.
Effects of DMTU in brain infarction following tMCAO in
mice
Figure 5 shows typical images of the brain following
tMCAO. Figure 5a shows ADC maps at 60 min during
ischemia. There was no difference in the reduction area
Fig. 4 Time changes in BBB permeability in the cortex and striatum following tMCAO in mice treated with saline or DMTU. a Representative of
Gd-DTPA-enhanced MR images at 1, 5, and 7 h after ischemia/reperfusion in mice treated with saline and DMTU. b Area of Gd-DTPA leakage was
evaluated as BBB permeability. T1-weighted images (T1WI) were acquired by spin echo multi-slice sequence before and after injection of Gd-DTPA.
Data are expressed as mean ± SD (n = 3–5 for each time point). *P < 0.05, **P < 0.01, as compared with control mice
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(56.1 ± 11.9 and 54.7 ± 9.5 mm3 in the saline and DMTU
groups, respectively; P = 0.809), suggesting that acute
ischemic damage was not influenced by DMTU treat-
ment. Figure 5b, c shows T2WI-weighted images and
TTC-stained sections at 24 h after tMCAO, respectively.
The contralateral hemisphere was stained as normal
tissue. A part of the cerebral cortex and the striatum
in the ipsilateral hemisphere were not stained for
mice treated with saline. We also found that in some
mice, the thalamus and hippocampus were injured.
The T2 hyperintensity area seemed to be comparable
with the unstained area of TTC. As shown in Fig. 6,
the percentage of the cerebral cortex (CTX-2) and
striatum (STR) was 59.6 ± 24.1 % and 86.3 ± 21.6 %
in the saline group, respectively. The infarct volume was
significantly attenuated by DMTU treatment. The total
infarct volumes of the saline and DMTU groups were
61.8 ± 12.7 % and 34.9 ± 25.5 % (P < 0.01 compared with
saline). Subregional analysis of the cerebral infarct
showed that infarcts in the thalamus (TH) andhippocampus (HIP) were 53.2 ± 30.9 % and 70.6 ± 53.5 %
in the saline-treated group. The DMTU groups showed
a smaller infarct volume in the cortex (31.4 ± 34.9 %)
and hippocampus (22.0 ± 35.7 %) (P < 0.05 compared
with saline).
Discussion
In the present study, we tried to detect the spatiotemporal
change of ROS generation in mouse brain following
ischemia/reperfusion. [3H]Hydromethidine, a radical
trapping radiotracer, was used for ROS detection. In
addition, in order to determine whether accumulation
of radioactivity after injection of [3H]hydromethidine
is attenuated by a free radical scavenger in the ischemic
region, we investigated the effects of DMTU, a hydroxyl
radical scavenger, on ROS generation and brain injury
after tMCAO in mice. As shown in Figs. 2 and 3, we
found that tMCAO produced a marked increase in
ROS production, which peaked at 5 h after reperfusion.
Accumulation of radioactivity, indicating ROS generation,
was observed in the ipsilateral hemisphere of the tMCAO
Fig. 6 Effect of DMTU on infarct volume following tMCAO in mice.
Infarct volume of the total, cortex (CTX-1, CTX-2), striatum (STR),
hippocampus (HIP), and thalamus (TH) of mice treated with vehicle
or DMTU (100 mg/kg, i.p.) 30 min before tMCAO (90 min) followed
by 24-h reperfusion. The infarct area in each slice was measured by
the following formula: ((area of the contralateral hemisphere − area
of non-ischemic ipsilateral hemisphere)/area of the whole contralateral
hemisphere) × 100. The infarct volume was determined by summing
up the infarct area of the 1–2 sections and is presented as the
percentage of the volume of the contralateral hemisphere. Data are
expressed as mean ± SD (n = 12–13 for each group). *P < 0.05,
**P < 0.01, as compared with saline
Fig. 5 Typical brain images following tMCAO in mice treated with
saline or DMTU. a ADC map during MCAO indicating acute ischemic
damage area in the brain acquired by MRI at 60 min after MCAO.
b T2WI-weighted images indicating infarct tissues (white region) in the
brain acquired by MRI at 24 h after ischemia/reperfusion of MCAO.
c TTC-stained coronal sections (2 mm thick) indicating infarct tissues
(pale unstained region) at 24 h after ischemia/reperfusion of MCAO.
Mice were treated with saline or DMTU 30 min before initiation
of MCAO
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first observed 1 h after reperfusion. The increase of
radioactivity was attenuated at 2 h after tMCAO and
then reached maximum at 5 h. The accumulation of
radioactivity was maintained until 7 h after tMCAO
although the level was lower than that at 5 h. The
time course of cortical accumulation was also similar to
that of the striatum. Hippocampal and thalamic accumu-
lation was also observed at 5 and 7 h after reperfusion in
some mice.
Many techniques have been used to detect the generation
of ROS in the brain. It is generally detected by indirectly
measuring secondary products such as oxidized protein,
peroxidized lipids, and oxidized DNA. Direct detection of
ROS has been done by using chemiluminescence, fluores-
cence, spin trapping, and microdialysis [15, 18, 22]. In vivo
microdialysis study showed that the formation of 2,3-
dihydroxybenzoic acid (2,3-DHBA) and 2,5-dihydroxy-
benzoic acid (2,5-DHBA), products of salicylate trapping
of hydroxyl radicals, increased in the striatum during acute
ischemia and reperfusion [18]. Increase of 2,3-DHBA and
2,5-DHBA was observed during ischemia, with high levels
being maintained until 2 h after reperfusion.
Temporal and spatial profiles of O2 · − after permanent
focal ischemia have been examined in mice using in situ
staining with dihydroethidium (DHE) [23]. They showedthat O2 · − generation increased 1 h after MCAO in the
ischemic core of the brain and in the boundary area of
the infarct zone between 3 and 6 h after permanent focal
brain ischemia. Fluorescence imaging using fluorescence
probe, 2-[6-(40-hydroxy)phenoxy-3H-xanthen-3-on-9-yl]
benzoic acid (HPF) revealed areas of enhanced HPF
fluorescence in both the ischemic core and peri-infarct
area at 4 h after MCAO in both the permanent and
transient MCAO models; the regions generating ROS
were more widespread than the areas of ischemic
damage [17]. These previous and our findings suggest
that ROS generation might be observed at several
hours after ischemia/reperfusion. The accumulation of
[3H]hydromethidine is thought to be due to ROS produc-
tion because [3H]hydromethidine was rapidly converted
to oxidized forms, which were trapped there in response
to the production of ROS. The amount of trapped
oxidized form were mainly dependent upon three factors,
the delivery process from plasma (regional cerebral blood
flow), the oxidation rate in the brain, and the washout
rate of unoxidized [3H]hydromethidine from the brain.
Therefore, in ischemic brain, the accumulation of
[3H]hydromethidine might be influenced by cerebral blood
flow and BBB permeability. It has been reported to decrease
cerebral blood flow in the ischemic side for more than
several hours after ischemia/reperfusion [24, 25]. These re-
ports suggest that the accumulation of [3H]hydromethidine
in the ischemic side was independent of regional cerebral
blood flow because regional cerebral blood flow seems to
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BBB disruption has been observed at several hours
after ischemia/reperfusion [26, 27]. In the present study,
we found that BBB disruption was not observed at 1 or
5 h after ischemia/reperfusion in the tMCAO (90 min)
model. These data indicate that the accumulation of
[3H]hydromethidine at 1 or 5 h after tMCAO might not
be affected by BBB disruption. In contrast, the accumula-
tion of [3H]hydromethidine at 7 h might be influenced by
BBB disruption. However, DMTU reduced the accumula-
tion of [3H]hydromethidine although it could not improve
striatal BBB disruption at 7 h after ischemia/reperfusion.
Thus, our result suggests that the accumulation of
[3H]hydromethidine in the ischemic area could be due to
ROS generation rather than input function such as
regional blood flow or BBB disruption. Our interesting
finding was that ROS generation was attenuated by the
control level at 2 h after reperfusion in the striatum and
cortex, ischemic core area. We clearly showed that the
accumulation was first observed at 1 h after reperfusion.
The increase of radioactivity was attenuated at 2 h after
reperfusion, and then, it peaked at 5 h. Antioxidant
enzymes, such as superoxide dismutase (SOD) and
glutathione peroxidase (GSHP), have been reported to
play an important role for ROS generation of tissue
affected by ischemia/reperfusion. An increase in GSHP
was observed in the parietal cortex at 1 h after ischemia/
reperfusion in the tMCAO rat model [28]. These previous
findings suggest that ROS generation might be regulated
by endogenous antioxidant activity in the brain after
ischemia/reperfusion.
ROS such as O2 · −, OH · −, and ONOO− are highly re-
active molecules that have been implicated in the patho-
genesis of secondary neuronal damage after ischemia/
reperfusion [29]. The superoxide radical (O2 · −) is usually
the primary ROS produced and is subsequently converted
into hydrogen peroxide (H2O2) through spontaneous or
SOD-catalyzed dismutation. The reaction of O2 · − and
NO generates the powerful oxidant ONOO−. Reaction of
H2O2 and ONOO− can generate the highly reactive
hydroxyl radical (OH · −) [30, 31]. The accumulation of
radioactivity observed in the ipsilateral hemisphere
suggests that [3H]hydromethidine might be oxidized
by ROS and then the oxidized form was trapped in
the tissue. We recently reported that [3H]hydromethidine
reacted with O2 · − and OH · − but not H2O2 from the
results of an in vitro study. Considering these in vitro
results, the accumulation of radioactivity in the brain
of our ischemic model strongly suggests that the oxidized
form of [3H]hydromethidine produced by OH · − or O2 · −
was trapped in the brain.
We also investigated the effects of DMTU, a hydroxyl
radical scavenger, on ROS generation and brain injury
after tMCAO in mice. DMTU is often used as a freeradical scavenger and can reduce brain damage due to
ischemia [32]. It has also been reported that DMTU re-
duced brain infarction and edema after permanent MCAO
in rats [33]. We also showed that DMTU could attenuate
brain infarction at 24 h after ischemia/reperfusion in the
mouse focal ischemia model. In addition, DMTU attenu-
ated the accumulation of radioactivity in the ipsilateral side
of the brain after reperfusion. These results suggest
that the accumulation of radioactivity induced by
tMCAO is to be mainly due to oxidative conversion
of [3H]hydromethidine by ROS such as OH · −. On
the other hand, DMTU increased radioactivity con-
centration of [3H]hydromethidine in the contralateral
side at 7 h after ischemia/reperfusion. The increase of
radioactivity concentration might be due to increased
cerebral blood flow induced by DMTU treatment.
Further studies will be needed to assess the effect of
DMTU on cerebral blood flow.
Reactive nitrogen species such as NO and ONOO− play
an important role in the process of cerebral ischemia/
reperfusion injury [34]. Superoxide can react with NO to
produce ONOO− that causes mitochondrial dysfunction,
and this leads to brain damage. We recently found that
[3H]hydromethidine was oxidized by ONOO− in in vitro
study (in-house data). Therefore, it is possible that
[3H]hydromethidine was oxidized by ONOO− in the brain
after ischemia/reperfusion. In addition, lipid peroxidation
of the cell membrane induced by ROS is considered to
oxidize [3H]hydromethidine in ischemia/reperfusion in the
brain. Thus, it might be difficult to identify the involvement
of specific species in brain injury after ischemia/reperfusion
because [3H]hydromethidine is oxidized by ROS such as
O2 · −, OH · −, or ONOO−. The present results suggest
[3H]hydromethidine to be a useful probe for assessing the
role of ROS in the ischemic brain state. Time-dependent
change of ROS could be detected in the same animals using
positron-labeled hydroethidine-related compounds because
hydromethidine can be labeled using [11C]methylation
instead of [3H]-labeling. Further studies including small-
animal PET studies using [11C]hydromethidine should be
very useful for studying the pathophysiological roles of
ROS in diseases such as ischemic stroke.Conclusions
The present study showed that [3H]hydromethidine is a
useful radiotracer for detecting in vivo brain ROS
production after ischemic injury. To the best of our
knowledge, this is the first report of the detection of brain
ROS generation after ischemia/reperfusion by using a
radical trapping radiotracer.Competing interests
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